Internal Reference Number: FOI_9323
Date Request Received: 01/04/2026 00:00:00
Date Request Replied To: 15/04/2026 00:00:00
This response was sent via: By Email
Request Summary: HAE & IG
Request Category: Companies
| Question Number 1: HAE: In the past 3 months [latest 3 months available] how many patients have received the following treatments [for any disease]: Berinert (Human C1-esterase inhibitor) Cinryze (Human C1-esterase inhibitor) Orladeyo (Berotralstat) Takhzyro (Lanadelumab) Ruconest (Recombinant human C1-esterase inhibitor) Firazyr (Icatibant injection) Icatibant - any brand except Firazyr | |
| Answer To Question 1: Please see our response to all questions in the spreadsheet attached. To accompany this answer to question 1 please also see the documents listed below:  13641 - FOI_9323 - HAE and IG - FOR ISSUE.xlsx | |
| Question Number 2: IG: In the past 3 months how many patients have received the following treatment for any disease: Octagam Gamunex Intratect Kiovig Gamten Panzyga Xembify Cuvitru Cutaquig Hyqvia | |
| Answer To Question 2: Please see our response to all questions in the spreadsheet attached. | |
| Question Number 3: In the past 3 months, how many patients have received any immunoglobulin treatment for the following diseases: Primary immunodeficiency (PID) Secondary immunodeficiency (SID) Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | |
| Answer To Question 3: Please see our response to all questions in the spreadsheet attached. | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at 星空无限 have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
